avapro has been researched along with Pulmonary Fibrosis in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alsayed, HA | 1 |
Mohammad, HMF | 1 |
Khalil, CM | 1 |
El-Kherbetawy, MK | 1 |
Elaidy, SM | 1 |
Marut, W | 1 |
Kavian, N | 1 |
Servettaz, A | 1 |
Hua-Huy, T | 1 |
Nicco, C | 1 |
Chéreau, C | 1 |
Weill, B | 1 |
Dinh-Xuan, AT | 1 |
Batteux, F | 1 |
2 other studies available for avapro and Pulmonary Fibrosis
Article | Year |
---|---|
Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin.
Topics: Animals; Autophagy; Bleomycin; Epithelial-Mesenchymal Transition; Irbesartan; Mammals; Pulmonary Fib | 2022 |
Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Biphenyl Compoun | 2013 |